APA (7th ed.) Citation

Huang, P., Kan, H., Hsu, C., Hsieh, H., Cheng, W., Huang, R., & You, J. (2023). A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity. Journal of Translational Medicine, 21(1), 1. https://doi.org/10.1186/s12967-023-04193-5

Chicago Style (17th ed.) Citation

Huang, Po-Lin, Hung-Tsai Kan, Ching-Hsuan Hsu, Hsin-Ta Hsieh, Wan-Chien Cheng, Ren-Yeong Huang, and Jhong-Jhe You. "A Bispecific Antibody AP203 Targeting PD-L1 and CD137 Exerts Potent Antitumor Activity Without Toxicity." Journal of Translational Medicine 21, no. 1 (2023): 1. https://doi.org/10.1186/s12967-023-04193-5.

MLA (9th ed.) Citation

Huang, Po-Lin, et al. "A Bispecific Antibody AP203 Targeting PD-L1 and CD137 Exerts Potent Antitumor Activity Without Toxicity." Journal of Translational Medicine, vol. 21, no. 1, 2023, p. 1, https://doi.org/10.1186/s12967-023-04193-5.